Crohn's Disease Clinical Trial
Official title:
Crohn's Extent of Resection Trial (CERT): A Randomised Controlled Trial Comparing Anastomotic Disease Recurrence Following 2cm Versus 10cm Resection Margins for Patients With Ileocolic Crohn's Disease
The trial will investigate if removing an additional length of small bowel will result in lower risk of recurrence at the surgical join (anastomosis), thereby decreasing the need for further surgery in the future.
The study will be conducted as a randomised controlled trial. The patient will be blinded to
the procedure undertaken, as will the endoscopist performing the 6 month post operative
colonoscopy. It is not possible to blind the operating team, for obvious reasons.
Patients undergoing elective or urgent ileocolic resection, both primary and redo resections,
will be invited to participate in the trial. Randomisation will take place in the operating
theatre after a conventional ileocolic resection has been performed. Those patients
randomised to the modest resection (10cm margin) will have an additional 8cm of distal small
bowel resected prior to the formation of the surgical anastomosis.
All patients will be seen in the colorectal clinic at approximately 6 weeks post operatively
for their routine follow up appointment, as is current practice. A colonoscopy will be
performed at 6 months post operatively to assess the anastomosis, in keeping with our current
practice. Any additional follow up will be at the discretion of the colorectal or
gastroenterological teams, in keeping with their clinical practice.
Patients recruited to the trial will not have any additional ongoing following up directly
related to their trial participation. At 5 years following the recruitment of the a patient,
the medical notes will be reviewed to identify those patients who have had symptomatic
recurrence, further surgery and to assess the duration of medication-free interval following
surgery.
Performing a colonoscopy at 6 months post operatively to assess the appearances of the
surgical anastomosis will assess the primary endpoint. This will be performed by a senior
gastroenterological trainee or consultant gastroenterologist who is familiar with assessment
of post operative Crohn's disease and the Rutgeert's score. The appearances of the
anastomosis will be scored, and biopsies taken from around the anastomosis to assess for
microscopic changes. The use of the Rutgeert's score is widely accepted by the
gastroenterological community as the standard assessment tool for post operative anastomotic
disease recurrence in patients with Crohn's disease.
The duration of medication-free interval following resection will be assessed from review of
the medical notes. This is clinically relevant to patients, as it has been previously shown
that quality of life is improved in patients who do not have to take regular medication.
The duration of symptom-free interval will be assessed from review of the medical notes. This
is clinically relevant to patients, as abdominal symptoms such as pain and bloating have a
significantly deleterious effect on quality of life.
The duration of time to reoperation for Crohn's disease recurrence at the surgical
anastomosis will be assessed from the clinical notes. This is of relevance to the patient
population as well as the medical community. Crohn's disease commonly recurs, necessitating
further surgery. Multiple operations resulting in resection of the bowel results in a
reduction in the length of bowel available for absorption of nutrients from food. Ultimately,
patients may develop short bowel syndrome. This requires total parenteral nutrition, with the
associated risks this carries, and may require small bowel transplantation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03815851 -
Relationship Between Prophylactic Drainage and Postoperative Complications (PPOI) in Crohn's Patients After Surgery
|
N/A | |
Not yet recruiting |
NCT06100289 -
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
|
Phase 3 | |
Completed |
NCT02883452 -
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis
|
Phase 1 | |
Recruiting |
NCT04777656 -
Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.
|
Phase 3 | |
Terminated |
NCT03017014 -
A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
|
||
Recruiting |
NCT06053424 -
Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease
|
Phase 1 | |
Recruiting |
NCT05428345 -
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
|
||
Completed |
NCT02508012 -
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
|
N/A | |
Not yet recruiting |
NCT02858557 -
The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases
|
N/A | |
Terminated |
NCT02882841 -
MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients
|
N/A | |
Completed |
NCT03010787 -
A First Time in Human Study in Healthy Volunteers and Patients
|
Phase 1 | |
Terminated |
NCT02417974 -
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
|
Phase 2 | |
Completed |
NCT02542917 -
Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study
|
||
Active, not recruiting |
NCT02316678 -
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
|
N/A | |
Completed |
NCT02193048 -
Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
|
||
Completed |
NCT02265588 -
Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT02154425 -
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
|
Phase 1 | |
Recruiting |
NCT02395354 -
Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease
|
N/A | |
Completed |
NCT01951326 -
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
|
Phase 3 |